Allergen rush immunotherapy increases interleukin (IL)-12 production and IL-12 receptor β2 chain expression in patients with allergic asthma
- 31 March 2004
- journal article
- clinical trial
- Published by Elsevier in Cellular Immunology
- Vol. 228 (1), 20-26
- https://doi.org/10.1016/j.cellimm.2004.03.008
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- PHA-induced IL-12Rβ2mRNA expression in atopic and non-atopic childrenClinical and Experimental Allergy, 2001
- Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthmaJournal of Allergy and Clinical Immunology, 1998
- Long-Term Analysis of Allergen-Specific T Cell Clones from Patients with Asthma Treated with Allergen Rush ImmunotherapyCellular Immunology, 1998
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 CellsThe Journal of Experimental Medicine, 1997
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsThe Journal of Experimental Medicine, 1997
- Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.The Journal of Experimental Medicine, 1995
- Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.The Journal of Experimental Medicine, 1993
- Treatment of steroid‐dependent asthma with recombinant interferon‐gammaClinical and Experimental Allergy, 1993